2 weeks Pharma Stock Roundup: LLY’s Zepbound Success, FDA Updates for MRK, JNJ Zacks
LLY’s Zepbound shows better weight loss than NVO’s Wegovy in a study. FDA updates for MRK, RHHBY, JNJ and AZN drugs grab headlines.
Eli Lilly (LLY) · Johnson & Johnson (JNJ) · Merck&Co (MRK)
X